Yamashita and co-workers defined 70 EpCAM co-expressed genes to construct a predictive model and define four HCC subgroups: HCC EpCAM positive with either AFP positive or negative and EpCAM negative with either AFP positive or negative. This evidence concerns the gene AFP and hepatocellular carcinoma.